Related Experiment Video
Updated: Jun 5, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Solid stress estimations via intraoperative 3D navigation in patients with brain tumors
Researchers developed a new method to measure physical forces, or solid stress, within brain tumors during surgery. This technique quantifies tissue loss and can help distinguish tumor types, potentially guiding personalized cancer treatment.
Area of Science:
- Biomedical Engineering
- Neurosurgery
- Oncology
Background:
- Physical forces from brain tumors, specifically solid stress, impact brain function but haven't been directly measured in patients.
- Previous estimations of solid stress correlate negatively with patient neurological performance.
- Measuring solid stress may inform clinical management strategies for brain tumors.
Purpose of the Study:
- To develop and validate an intraoperative technique for quantitatively measuring solid stress and brain tissue replacement in patients with brain tumors.
- To explore the potential of solid stress and tissue loss as clinical biomarkers for brain tumors.
- To investigate the correlation between solid stress, tissue loss, and tumor type.
Main Methods:
- Developed an intraoperative technique combining neuro-navigation and finite element modeling to estimate solid stress and brain tissue replacement.
- Measured brain deformation in 30 patients during surgical procedures immediately prior to tumor resection.
- Calculated solid stress and quantified the volume of brain tissue lost due to tumor growth.
Main Results:
- Mean solid stresses ranged from 10 to 600 Pa, with tissue replacement up to 10% of brain volume.
- Quantified solid stress and tissue loss in 30 patients, distinguishing glioblastoma from brain metastatic tumors.
- Demonstrated that solid stress serves as a sensitive biomarker for chemotherapy response in mice.
Conclusions:
- Presented a novel, quantitative intraoperative approach to measure solid stress in brain tumor patients, adaptable to clinical workflows.
- Established brain tissue loss as a novel mechanical biomarker, alongside solid stress, for personalized brain cancer management.
- Highlighted the potential of these physical biomarkers to predict patient outcomes and guide clinical decision-making.
More Related Videos
13:12Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
05:37Cone Beam Intraoperative Computed Tomography-based Image Guidance for Minimally Invasive Transforaminal Interbody Fusion
Published on: August 6, 2019